Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
San Diego, California (ots/PRNewswire) - - Newly Established Organization Presents Data on Advancing Compounds at AACR - Ortho Biotech Oncology Research & Development (ORD), a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., will announce results from studies of three innovative ...
mehr